My Intelligent Machines

At My Intelligent Machines, we are helping life scientists harness the power of human and artificial intelligence to push the boundaries of drug development. MIMs is a software-as-a-service (SaaS) company with an augmented-intelligence platform leveraging systems biology, distributed computing, and machine learning to unleash the power of reverse translational research. We are changing the research paradigm for endotype characterization, target and indication prioritization, and target and biomarker discovery, in oncology, immune-related disorders, infectious diseases, and more. MIMs’ transformational software solutions are made possible by an inclusive team of remarkable and diverse humans – leaders of today and tomorrow in their respective fields. MIMs’ platform integrates our MIMsight Knowledge Base—which combines billions of data points and other information extracted from scientific literature, public databases, and multi-omic and clinical patient data-and our proprietary GI2 (Genetic Interaction Graph Inference) algorithm inferring genetic interactions within patient tumours and immune systems.